INDV Stock Indivior (INDV, $32.26) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 18, 2025
at Tickeron.com
This is a Bullish indicator signaling INDV's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 45 similar cases where INDV's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:
INDV's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for INDV turned positive on November 18, 2025. Looking at past instances where INDV's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INDV advanced for three days, in of 184 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 287 cases where INDV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INDV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
INDV broke above its upper Bollinger Band on October 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INDV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: INDV's P/B Ratio (147.059) is slightly higher than the industry average of (17.117). P/E Ratio (33.265) is within average values for comparable stocks, (71.877). INDV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.887). INDV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (3.530) is also within normal values, averaging (54.918).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Advertisement
General Information
Industry PharmaceuticalsGeneric